ClinicalTrials.Veeva

Menu

A Study of the Intestinal Microbiome in Patients with Cirrhosis (IIT_MicroB)

Yonsei University logo

Yonsei University

Status

Not yet enrolling

Conditions

Liver Cirrhosis

Treatments

Other: Determine the gut microbiome at baseline and 12 months.

Study type

Observational

Funder types

Other

Identifiers

NCT06808698
IIT_MicroB

Details and patient eligibility

About

This study aims to establish a cohort for analyzing the gut microbiome of patients with liver cirrhosis and to identify factors that influence the prognosis of these patients.

Enrollment

100 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Aged 19 years or older:
  2. Patients visiting the hospital with liver cirrhosis.
  3. Patients diagnosed with liver cirrhosis who can understand the information provided to them or their representatives and have voluntarily given written consent to participate in this study

Exclusion criteria

  1. Cases not meeting the inclusion criteria
  2. Patients who refuse participation
  3. Patients who have taken or been administered antibiotics within the past 2 weeks or are scheduled to take or receive antibiotics during the study period
  4. Cases where the diagnosis is unclear
  5. Cases with incomplete data or missing investigation items
  6. Individuals deemed unsuitable by the principal investigator for other reasons

Trial design

100 participants in 1 patient group

Patients with cirrhosis
Description:
Patients with cirrhosis
Treatment:
Other: Determine the gut microbiome at baseline and 12 months.

Trial contacts and locations

0

Loading...

Central trial contact

Hye Won Professor Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems